Lupus & antiphospholipid syndrome

Genetic landscape of early-onset systemic lupus erythematous in India

Rheumatology (Oxford)Published Prospective observational study

An erratum to this article was published (Rheumatology (Oxford), 1 Aug 2026 ↗)

Authors' conclusion

Monogenic causes were found in at least 6.1% of the overall cohort of pSLE and in 22.7% of genetically screened cases, with the highest yield in EOSLE (28.4%). C1QA was the most common single-gene defect (7.2%).

Study context

Population
Indian pediatric SLE (pSLE) cohort: patients with early-onset systemic lupus erythematosus (EOSLE) (age ≤8 years) and/or clinical suspicion of monogenic lupusof 365 pSLE patients
Participants
97 participants
Exposure
EOSLE vs Older children
Outcome
Monogenic causes (pathogenic variants) of EOSLE
Methodological detailsgenetic screening: targeted next-generation sequencing and whole-exome sequencing, Targeted NGS (Ion S5) in 55 of 97 (complement defect panel in 28; Interferon (IFN)+ Adaptive Immunity panel in 27); Whole-exome sequencing (WES) in remaining 42
  • Genetic screening: targeted next-generation sequencing and whole-exome sequencing
  • Targeted NGS (Ion S5) in 55 of 97 (complement defect panel in 28; IFN+ Adaptive Immunity panel in 27); WES in remaining 42

Main finding

As reported in the abstract

Pathogenic variants (monogenic lupus)

Patients carrying pathogenic variants among 97 screened

22

22.68%

Diagnostic yield, EOSLE

28.4%

Diagnostic yield, older children

4.4%

Monogenic causes in overall pSLE cohort

at least 6.1%

Observational data: associations, not effects.

Further findings

Characteristics of monogenic cases

Median symptom onset (range 2 months to 9 years)
2 years
Consanguinity
7/22 (31.8%)
Sex
11 boys and 11 girls

Genes with variants

C1QA
7
C1QC
2
C1QB
1
C1R
1
C3
2
ACP5
2
STING1, DNASE2, ADAR, TREX1, DNASE1L3, PEPD and SLC7A7 (each)
1
C1QA, most common single-gene defect
7.2%

Original publication

Genetic landscape of early-onset systemic lupus erythematous in India. Rheumatology (Oxford). Published 27 November 2025. doi:10.1093/rheumatology/keaf631

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.